Iron deficiency anemia: When is parenteral therapy warranted?

Postgraduate Medicine

Volumn 100, Issue 5, 1996, Pages

  Swain, Randall A ^a   Kaplan, Barbara ^a   Montgomery, Emily ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ANTIHISTAMINIC AGENT; ASCORBIC ACID; CORTICOSTEROID; FERROUS FUMARATE; FERROUS GLUCONATE; FERROUS SULFATE; HISTAMINE H2 RECEPTOR ANTAGONIST; IRON; IRON DEXTRAN; IRON SACCHARATE; LEVODOPA; METHYLDOPA; PROTON PUMP INHIBITOR; QUINOLONE DERIVATIVE; TETRACYCLINE DERIVATIVE;

ADULT; ANAPHYLAXIS; CASE REPORT; DRUG COST; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; IRON ABSORPTION; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON STORAGE; IRON THERAPY; LABORATORY TEST; MALE; ORAL DRUG ADMINISTRATION; PARENTERAL DRUG ADMINISTRATION; REVIEW;

EID: 10544230645     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1996.11.116     Document Type: Review

References (15)

1. DeMaeyer E, Adiels-Tegman M. The prevalence of anaemia in the world. World Health Stat Q 1985;38(3):302-16
2. Fomon SJ, Ziegler EE, Nelson SE, et al. Cow milk feeding in infancy: gastrointestinal blood loss and iron nutritional status. J Pediatr 1981;98(4):540-5
3. Gilles HM. Selective primary health care: strategies for control of disease in the developing world. XVII. Hookworm infection and anemia. Rev Infect Dis 1985;7(1):111-8
4. Morck TA, Lynch SR, Cook JD. Inhibition of food iron absorption by coffee. Am J Clin Nutr 1983;37(3):416-20
5. Muñoz LM, Lönnerdal B, Keen CL, et al. Coffee consumption as a factor in iron deficiency anemia among pregnant women and their infants in Costa Rica. Am J Clin Nutr 1988;48(3):645-51
6. Cook JD. Iron deficiency anemia. In: Brain MC, Carbone P, eds. Current therapy in hematology and oncology. 3d ed. St Louis: Mosby-Year Book, 1987:9-11
7. Hillman RS, Henderson PA. Control of marrow production by the level of iron supply. J Clin Invest 1969;48(3):454-60
8. Hamstra RD, Block MH, Schocket AL. Intravenous iron dextran in clinical medicine. JAMA 1980;243(17):1726-31
9. Kumpf VJ, Holland EG. Parenteral iron dextran therapy. DICP 1990;24(2):162-6
10. Greenberg G. Sarcoma after intramuscular iron injection. Br Med J 1976;1(6024):1508-9
11. Blake DR, Lunec J, Ahern M, et al. Effect of intravenous iron dextran on rheumatoid synovitis. Ann Rheum Dis 1985;44(3):183-8
12. Oh VM. Iron dextran and systemic lupus erythematosus. (Letter) BMJ 1992;305(6860):1000
13. Blake DR, Hall ND, Bacon PA, et al. The importance of iron in rheumatoid disease. Lancet 1981;2(8256):1142-4
14. Ron D. The reticuloendothelial system and rheumatoid arthritis. (Letter) Lancet 1979;2(8148):901
15. Monaghan MS, Glasco G, St John G, et al. Safe administration of iron dextran to a patient who reacted to the test dose. South Med J 1994;87(10):1010-2